Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
This study will evaluate the safety, reactogenicity and immunogenicity of Mtb72F/AS02A in healthy European volunteers who are PPD-positive either via previous vaccination with BCG and/or conversion to PPD positivity through exposure to Mycobacterium tuberculosis.
Epistemonikos ID: 1fde1c743e4c439f6b9e8ff95d9eb6e7355fc511
First added on: May 04, 2024